Greenhalf W - Search Results

1

The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements.

Ashworth M, Small B, Oldfield L, Evans A, Greenhalf W, Halloran C, Costello E. Ashworth M, et al. Among authors: greenhalf w. Sci Rep. 2021 Mar 22;11(1):6487. doi: 10.1038/s41598-021-85052-5. Sci Rep. 2021. PMID: 33753773 Free PMC article.

2

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.

Halloran CM, Ghaneh P, Shore S, Greenhalf W, Zumstein L, Wilson D, Neoptolemos JP, Costello E. Halloran CM, et al. Among authors: greenhalf w. J Gene Med. 2004 May;6(5):514-25. doi: 10.1002/jgm.540. J Gene Med. 2004. PMID: 15133762

3

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.

Vimalachandran D, Greenhalf W, Thompson C, Lüttges J, Prime W, Campbell F, Dodson A, Watson R, Crnogorac-Jurcevic T, Lemoine N, Neoptolemos J, Costello E. Vimalachandran D, et al. Among authors: greenhalf w. Cancer Res. 2005 Apr 15;65(8):3218-25. doi: 10.1158/0008-5472.CAN-04-4311. Cancer Res. 2005. PMID: 15833853

4

Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer.

Yan L, Tonack S, Smith R, Dodd S, Jenkins RE, Kitteringham N, Greenhalf W, Ghaneh P, Neoptolemos JP, Costello E. Yan L, et al. Among authors: greenhalf w. J Proteome Res. 2009 Jan;8(1):142-8. doi: 10.1021/pr800451h. J Proteome Res. 2009. PMID: 19055369

5

Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer.

Shaw VE, Naisbitt DJ, Costello E, Greenhalf W, Park BK, Neoptolemos JP, Middleton GW. Shaw VE, et al. Among authors: greenhalf w. Expert Rev Vaccines. 2010 Sep;9(9):1007-16. doi: 10.1586/erv.10.92. Expert Rev Vaccines. 2010. PMID: 20822343 Free article. Review.

6

Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.

Tweedle EM, Khattak I, Ang CW, Nedjadi T, Jenkins R, Park BK, Kalirai H, Dodson A, Azadeh B, Terlizzo M, Grabsch H, Mueller W, Myint S, Clark P, Wong H, Greenhalf W, Neoptolemos JP, Rooney PS, Costello E. Tweedle EM, et al. Among authors: greenhalf w. Gut. 2010 Nov;59(11):1501-10. doi: 10.1136/gut.2009.196626. Gut. 2010. PMID: 20947885

7

New biomarkers and targets in pancreatic cancer and their application to treatment.

Costello E, Greenhalf W, Neoptolemos JP. Costello E, et al. Among authors: greenhalf w. Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):435-44. doi: 10.1038/nrgastro.2012.119. Epub 2012 Jun 26. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22733351 Review.

8

iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance.

Tonack S, Jenkinson C, Cox T, Elliott V, Jenkins RE, Kitteringham NR, Greenhalf W, Shaw V, Michalski CW, Friess H, Neoptolemos JP, Costello E. Tonack S, et al. Among authors: greenhalf w. Br J Cancer. 2013 May 14;108(9):1846-53. doi: 10.1038/bjc.2013.150. Epub 2013 Apr 11. Br J Cancer. 2013. PMID: 23579209 Free PMC article.

9

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

Greenhalf W, Ghaneh P, Neoptolemos JP, Palmer DH, Cox TF, Lamb RF, Garner E, Campbell F, Mackey JR, Costello E, Moore MJ, Valle JW, McDonald AC, Carter R, Tebbutt NC, Goldstein D, Shannon J, Dervenis C, Glimelius B, Deakin M, Charnley RM, Lacaine F, Scarfe AG, Middleton MR, Anthoney A, Halloran CM, Mayerle J, Oláh A, Jackson R, Rawcliffe CL, Scarpa A, Bassi C, Büchler MW; European Study Group for Pancreatic Cancer. Greenhalf W, et al. J Natl Cancer Inst. 2014 Jan;106(1):djt347. doi: 10.1093/jnci/djt347. Epub 2013 Dec 3. J Natl Cancer Inst. 2014. PMID: 24301456 Clinical Trial.

10

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.

Shaw VE, Lane B, Jenkinson C, Cox T, Greenhalf W, Halloran CM, Tang J, Sutton R, Neoptolemos JP, Costello E. Shaw VE, et al. Among authors: greenhalf w. Mol Cancer. 2014 May 20;13:114. doi: 10.1186/1476-4598-13-114. Mol Cancer. 2014. PMID: 24884871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters